ABSTRACT
AIM: This study evaluates and correlates the number of myocarditis focuses and production of cytokines in Rattus norvegicus (Wistar lineage), experimentally infected with T. Cruzi and treated with Phosphorus. METHODS: In two blind, controlled and randomized trials, 53 45-day-old, male animals were allocated into groups Control (n=24): Control group infected and treated with 7% hydroalcoholic solution, the preparation vehicle of the test medication; and Phosphorus (n=24 on days 0, 5, 10 and 24 after infection): group infected and treated with Phosphorus 13cH, diluted 10-26 and dynamized (test medication). The animals were inoculated intraperitoneally with 5×106 blood trypomastigotes of T. cruzi-Y strain. The medication was administered overnight (16 consecutive hours), diluted in water (1mL/100mL) in amber water bottles. The animals were treated 2days before and 2, 4, and 6days after infection. Enumeration of inflammatory foci in cardiac tissue (Hematoxylin-Eosin) and dosage of cytokines TNF-α and IFN-γ in the serum were performed on days 0, 5, 10 and 24 after infection, using three animals/group. Mann-Whitney, Friedman ANOVA, Spearman correlation (p<0.05), and Statistica Single User Software version 13.2 were used for data analysis. RESULTS: The animals treated with Phosphorus 13cH had high concentration of INF-É£ on the 5th day of infection with significant decrease on the 10th and 24th days (p<0.05), and high concentration of TNF-α on the 5th and 10th days of infection with decrease on the 24th day (p<0.05). The treatment with Phosphorus caused a significant increase of INF-É£ and TNF-α on the 5th day of infection compared with the Control (p<0.05), with reestablishment on the 24th day, as well as in the Control group. The group treated with Phosphorus had 52.5% less number of myocarditis focuses in heart than Control group (p<0.05) on the 10th day of infection. The significant increase in cytokines on the5th day of infection in the Phosphorus group is related to a significant decrease in the number of inflammatory foci in cardiac tissue on the 10th day of infection in this group. DISCUSSION AND CONCLUSION: Treatment with Phosphorus 13cH promotes beneficial effects in T. cruzi infection in Wistar rats by modulating the secretion of IFN-γ and TNF-α with decreased inflammation in cardiac tissue. These results reinforce the importance of considering the use of homeopathy for establishing new therapeutic approaches in the management of patients with Chagas disease.
Subject(s)
Cardiotonic Agents/pharmacology , Chagas Disease/drug therapy , Chagas Disease/immunology , Heart/drug effects , Myocardium/immunology , Phosphorus/pharmacology , Animals , Chagas Disease/pathology , Disease Models, Animal , Heart/parasitology , Homeopathy , Interferon-gamma/blood , Male , Myocardium/pathology , Rats , Rats, Wistar , Trypanosoma cruzi/immunology , Tumor Necrosis Factor-alpha/bloodABSTRACT
BACKGROUND: Changes in serum concentrations of tumor necrosis factor-α (TNF-α) and its soluble receptors (sTNF-R) p55 and p75 have been shown to be associated with various psychiatric treatments. SUBJECTS AND METHODS: Before and after treatment, serum levels of TNF-α, sTNF-R p55 and sTNF-R p75 were measured in 38 German soldiers who had been deployed abroad and suffered from combat-related post-traumatic stress disorder (PTSD). Patients were randomized either to inpatient psychotherapy (N=21) including eye movement desensitization and reprocessing (EMDR) or to outpatient clinical management (N=17). Symptoms of PTSD were measured using the Post-traumatic Stress Diagnostic Scale (PDS). RESULTS: The PDS score significantly decreased across time in both groups. Serum concentrations of TNF-α increased, while sTNF-R p55 and sTNF-R p75 levels decreased significantly. After the treatment period, we could not detect any significant difference regarding TNF-α, sTNF-R p55 or sTNF-R p75 levels between the inpatient psychotherapy group and the outpatient clinical management control group. CONCLUSIONS: This relatively small clinical study suggests that specific inpatient psychotherapy but also non-specific supportive outpatient treatment for PTSD are associated with changes in the TNF-α system. This may represent an immunological effects or side effects of psychotherapy.
Subject(s)
Combat Disorders/blood , Combat Disorders/therapy , Military Personnel/psychology , Psychotherapy , Receptors, Tumor Necrosis Factor, Type I/blood , Stress Disorders, Post-Traumatic/blood , Stress Disorders, Post-Traumatic/therapy , Tumor Necrosis Factor-alpha/blood , Adult , Ambulatory Care , Antidepressive Agents/therapeutic use , Combat Disorders/psychology , Combined Modality Therapy , Cross-Sectional Studies , Humans , Longitudinal Studies , Male , Materia Medica/therapeutic use , Middle Aged , Patient Admission , Stress Disorders, Post-Traumatic/psychologyABSTRACT
OBJECTIVE: To investigate the antitumor effects of Gecko alcohol extract and its synergism and attenuation effects on CTX. METHOD: S180-bearing mice were given Gecko alcohol extract via intravenous injection,the tumor inhibitory rate and the levels of serum TNF-alpha of mice were detected. After inoculation of S180 tumor, the synergism and attenuation effects of Gecko alcohol extract on CTX were observed. After 12 days treatment, the tumor inhibitory rate, the count of peripheral white blood cells, index of thymus and spleen were calculated. RESULTS: Gecko alcohol extract in different dose (0.6, 1.2, 2.4 g/kg) inhibited the growth of S180 sarcoma in KM mice. The tumor inhibitory rates of 0.6, 1.2, 2.4 g/kg Gecko alcohol extract were 44.88%, 63.94%, 69.53%, respectively. However, the levels of serum TNF-alpha of mice not changed. The tumor inhibitory rates of intravenous administration of 0.6, 1.2, 2.4 g/ kg Gecko alcohol extract combined with CTX (20 mg/kg) were 56.93%, 67.15%, 70.24%, which were higher than that of CTX administration alone (41.71%). Compared with those in CTX group, the count of WBC (P < 0.01), the indexes of thymus and spleen (P < 0.05) were significantly elevated in all Gecko alcohol extract and CTX combination groups. CONCLUSION: Gecko alcohol extract has anti-tumor effects in vivo and attenuation effects on CTX.
Subject(s)
Antineoplastic Agents/pharmacology , Cyclophosphamide/pharmacology , Lizards , Materia Medica/pharmacology , Sarcoma 180/drug therapy , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/isolation & purification , Cell Survival/drug effects , Cyclophosphamide/administration & dosage , Cyclophosphamide/adverse effects , Drug Interactions , Enzyme-Linked Immunosorbent Assay , Ethanol/chemistry , Injections, Intraperitoneal , Male , Materia Medica/administration & dosage , Materia Medica/isolation & purification , Mice , Sarcoma 180/pathology , Spleen/drug effects , Thymus Gland/drug effects , Tumor Necrosis Factor-alpha/bloodABSTRACT
OBJECTIVE: To explore the clinical curative effect and safety of Jiedu Tongluo Lishi decoction on treating active rheumatoid arthritis (RA). METHOD: 106 cases of RA in active period were randomly divided into the integrated Chinese and western medicine group (n=54) and western medicine contrast group (n=52). The former group were treated by Jiedu Tongluo Lishi decoction combined with SASP, the latter by MTX combined with SASP. The arthritis morning stiffness time, ache indexes, tumidness indexes, function indexes, hands grip, 20-m walking time and experimental indexes including ESR, RF, CRP, C3, immune globin of both groups were observed and compared. RESULT: The obviously clinical effective ratio and the total clinical effective ratio in the former group were 77.78% and 90.74% respectively, which are better than those in the latter group (59.62% and 71.15% respectively) (P < 0.01). The arthritis morning stiffness time, ache indexes, tumidness indexes, function indexes, hands grip and 20-m walking time in both groups were obviously released after treatment (P < 0.01). The clinical release in the former group was better than that in the latter group (P < 0.05). ESR, RF and CRP in both groups were markedly improved (P < 0.05). The improvement of ESR, RF, CRP, C3 and IgA in the former group were better than those in the latter group (P < 0.05). The side effect includes gastroenteric tract reaction, decrease of leucocyte, abnormity of liver function, tetter and catamenia maladjustment. The occurent ratio in the former group was 7.41%, which was obviously lower than that in the latter group (15.38%) (P < 0.01). CONCLUSION: The compositively clinical curative effect of Jiedu Tongluo Lishi decoction combined with MTX on treating RA is obviously better than that of western medicine only such as MTX and SASP, with less side effect and higher safety, which is worth applying in clinics extensively.